• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响腱膜巨细胞瘤早期发生骨关节炎的风险因素。

Risk factors for early osteoarthritis in tenosynovial giant cell tumour.

机构信息

Departamento de Cirugía Ortopédica y Traumatología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

Departamento de Cirugía Ortopédica y Traumatología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

出版信息

Rev Esp Cir Ortop Traumatol (Engl Ed). 2020 May-Jun;64(3):199-205. doi: 10.1016/j.recot.2019.12.001. Epub 2020 Jan 21.

DOI:10.1016/j.recot.2019.12.001
PMID:31980414
Abstract

OBJECTIVE

Tenosynovial giant cell tumour (TGCT) is locally aggressive entity affecting young people (around 4 decade of life) and can cause joint destruction. It could be nodular or diffuse. These two varieties are histological and genetically similar, but present a different prognosis. The aim of this study is to identify risk factors for local recurrence and predisposing factors for the development of early osteoarthritis in patients with TGCT.

MATERIAL AND METHODS

We conducted a retrospective study of 35 patients with an anatomopathological diagnosis of TGCT in our Institution from 1991 to 2017. The mean follow-up was 8.2 years. Demographic variables, characteristics of the primary tumor and its evolution were collected to assess the risk factors for local recurrence and early osteoarthritis.

RESULTS

The diffuse type was identified as a risk factor for the development of osteoarthritis (p=0.01) and for local recurrence (p=0.015). Osteoarthritis was more frequent in the hip and ankle than in the knee (p=0.03). A difference of 16 months in the duration of symptoms prior to diagnosis between those who developed osteoarthritis and those who did not was observed (p=0.05).

CONCLUSIONS

The diffuse type is more aggressive than the nodular type; it is associated with a higher risk of osteoarthritis and local recurrence. The hip and ankle present a higher risk of osteoarthritis than other joints. The time of evolution of the symptoms before diagnosis and adequate treatment, negatively influences the development of osteoarthritis.

摘要

目的

腱鞘巨细胞瘤(TGCT)是一种局部侵袭性肿瘤,主要影响年轻人(40 岁左右),可导致关节破坏。它可以是结节性或弥漫性。这两种类型在组织学和遗传学上相似,但预后不同。本研究的目的是确定 TGCT 患者局部复发的危险因素和发生早期骨关节炎的易患因素。

材料和方法

我们对 1991 年至 2017 年在我院接受 TGCT 解剖病理学诊断的 35 例患者进行了回顾性研究。平均随访时间为 8.2 年。收集了人口统计学变量、原发性肿瘤的特征及其演变情况,以评估局部复发和早期骨关节炎的危险因素。

结果

弥漫型被认为是发生骨关节炎的危险因素(p=0.01)和局部复发的危险因素(p=0.015)。髋关节和踝关节比膝关节更容易发生骨关节炎(p=0.03)。发生骨关节炎和未发生骨关节炎的患者在诊断前症状持续时间上存在 16 个月的差异(p=0.05)。

结论

弥漫型比结节型更具侵袭性;它与更高的骨关节炎和局部复发风险相关。髋关节和踝关节比其他关节更容易发生骨关节炎。诊断前症状的演变时间和适当的治疗会对骨关节炎的发展产生负面影响。

相似文献

1
Risk factors for early osteoarthritis in tenosynovial giant cell tumour.影响腱膜巨细胞瘤早期发生骨关节炎的风险因素。
Rev Esp Cir Ortop Traumatol (Engl Ed). 2020 May-Jun;64(3):199-205. doi: 10.1016/j.recot.2019.12.001. Epub 2020 Jan 21.
2
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.弥漫型腱鞘巨细胞瘤患者的手术治疗效果:一项国际性回顾性队列研究。
Lancet Oncol. 2019 Jun;20(6):877-886. doi: 10.1016/S1470-2045(19)30100-7. Epub 2019 Apr 24.
3
Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature.腱鞘巨细胞瘤:开放手术还是关节镜下滑膜切除术?文献系统评价
Orthop Traumatol Surg Res. 2017 Sep;103(5):809-814. doi: 10.1016/j.otsr.2017.03.016. Epub 2017 Apr 17.
4
Management of tenosynovial giant cell tumour of the foot and ankle.足部和踝关节腱鞘巨细胞瘤的治疗。
Bone Joint J. 2021 Apr;103-B(4):788-794. doi: 10.1302/0301-620X.103B4.BJJ-2020-1582.R1.
5
Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.在足跟部腱鞘巨细胞瘤患者中,不完全切除会增加局部复发的风险,并对功能结果产生负面影响。
Foot Ankle Surg. 2020 Oct;26(7):822-827. doi: 10.1016/j.fas.2019.10.014. Epub 2019 Dec 5.
6
Distraction arthroplasty combined with autologous bone grafting for diffuse-type tenosynovial giant cell tumour with articular cartilage defect and subchondral bone cysts: A case report.关节内软骨缺损及软骨下骨囊肿的弥漫型腱鞘巨细胞瘤采用关节成形术联合自体骨移植治疗:1 例报告。
Mod Rheumatol Case Rep. 2023 Jun 19;7(2):483-487. doi: 10.1093/mrcr/rxac092.
7
The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.手术对腱鞘巨细胞瘤患者生活质量和关节功能的影响:基于患者报告结局的评估。
Bone Joint J. 2019 Mar;101-B(3):272-280. doi: 10.1302/0301-620X.101B3.BJJ-2018-0804.R1.
8
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.患者报告的腱鞘巨细胞瘤症状。
Clin Ther. 2016 Apr;38(4):778-93. doi: 10.1016/j.clinthera.2016.03.008. Epub 2016 Apr 1.
9
Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.足踝部腱鞘巨细胞瘤的治疗结果
Foot Ankle Int. 2023 Oct;44(10):1013-1020. doi: 10.1177/10711007231189491. Epub 2023 Aug 30.
10
Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty.全膝关节置换术中诊断出的晚期膝关节腱鞘巨细胞瘤的预后
J Arthroplasty. 2017 Jun;32(6):1850-1855. doi: 10.1016/j.arth.2016.12.053. Epub 2017 Jan 11.

引用本文的文献

1
The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review.腱鞘巨细胞瘤的经济和人文负担:一项针对性文献综述
Future Oncol. 2025 Aug;21(18):2385-2400. doi: 10.1080/14796694.2025.2520744. Epub 2025 Jun 22.
2
Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?弥漫型腱鞘巨细胞瘤:初次及随访MRI的重要发现有哪些?
Cancers (Basel). 2024 Jan 17;16(2):402. doi: 10.3390/cancers16020402.
3
The causal relationship between osteoarthritis and bladder cancer: A Mendelian randomization study.
骨关节炎与膀胱癌之间的因果关系:一项孟德尔随机化研究。
Cancer Med. 2024 Jan;13(1):e6829. doi: 10.1002/cam4.6829. Epub 2023 Dec 15.
4
Understanding the Effect of Osteoarthritis on Surgical Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients With Tenosynovial Giant Cell Tumors.了解骨关节炎对腱鞘巨细胞瘤患者手术治疗模式、医疗资源利用和成本的影响。
J Am Acad Orthop Surg Glob Res Rev. 2023 May 22;7(5). doi: 10.5435/JAAOSGlobal-D-23-00047. eCollection 2023 May 1.